High Times reports a small clinical trial of an experimental medication for cannabis withdrawal. Here’s what we know now, how it could work, and what DMV patients should watch.

A new film centers an artist with three days left, stirring questions about love, grief, creativity—and how the cannabis lifestyle gathers us around stories that matter.

The Cannabis Cup touches down in Buenos Aires in October and San Juan in December, signaling a cross‑continental moment for cannabis culture with ripple effects in the DMV.

DEA’s 2026 Drugs of Abuse update says no deaths from marijuana overdose and reflects federal moves toward Schedule III for certain cannabis products. Here’s what it means in practice.

Oregon pauses a proposed psilocybin fee increase, California earmarks $4.7M for psychedelic research, and the DEA moves to schedule five tryptamines—here’s why it matters.

Steven Froelich’s cocaine tale from Guatemala hits High Times. Here’s what it is (a personal narrative), what it isn’t (a policy change), and why DMV readers should care.

High Times reports Italy’s fentanyl scarcity despite entrenched opioid use and powerful crime networks. We unpack what that evidence means for drug markets—and the cannabis delivery business.

In a unanimous move, Portland will make personal, non-commercial use and sharing of natural psychedelics a low police priority—without legalizing sales or impaired driving.

New EEG findings highlighted by DoubleBlind suggest baseline brain rhythms can forecast how intense an ayahuasca experience may feel—useful context for DMV readers.

From desert land art to neon museums and ancient necropolises, here are awe-heavy settings—and practical planning notes—if you care about set and setting.

As microdosing goes mainstream, here’s how to decide between a solo approach or working with a coach—plus DMV-specific considerations and compliance tips.

A practical, ethical guide to talking with parents about psilocybin—what to say, how to support them, and what DC, Maryland, and Virginia residents should know.

Psychedelic Alpha flagged a busy “Psychedelics Week” in DC with multiple meetings. Here’s what that activity could signal for policy, access, and the DMV community.

Pierce County, Nevada City and Portland advance measures to make personal use of natural psychedelics a low police priority—without legalizing them—signaling a local-first policy trend.

A new UC San Diego analysis of 21,189 adults aged 65+ found 11.4% of past-year cannabis users met DSM-5 criteria for cannabis use disorder, with most cases mild.

Submersion Festival is trading the discreet smoking circle for a central, curated cannabis village. Here’s what their blueprint means for the future of events and the DMV's cannabis lifestyle.

Exploring how shared mushroom experiences foster deep human connection amidst evolving drug policy across the DMV region.

Learn how survivor-built vetting frameworks use color-coded flags to help consumers identify ethical guides and avoid abuse.

A 1960s hoax claimed banana peels could get you high. Here’s what actually happened, what the FDA and researchers found, and why rumor-busting still matters in the DMV.

Definium Therapeutics reports another positive Phase 3 readout for DT120 in generalised anxiety disorder, with randomized data from the Panorama study now toplined.